Product Information
FEXOFENADINE HCL 60 MG TABLET is a generic product labeled by Camber Consumer Care, priced at $0.1529 per EA under NDC 69230020105. Its NADAC has been published 243 times since Feb 9, 2022.
FDA first approved this application on Sep 16, 2015.
Strength
60 mg/1
Manufacturer
Camber Consumer CareNDC
69230020105
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FEXOFENADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204507FDA Approved
9/16/2015
On Market Since
12/8/2021
Pharmacological Classes
Price Statistics
The NADAC for FEXOFENADINE HCL 60 MG TABLET has been published 243 times since Feb 9, 2022, and over the history we have for it it has risen 7.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1529 per EA |
|---|---|
| All-time high | $0.1994 (Apr 10, 2024) |
| All-time low | $0.1254 (May 22, 2024) |
| 52-week high | $0.1767 |
| 52-week low | $0.1512 |
| Median price | $0.1700 |
| Average price | $0.1681 |
| Largest weekly change | +46.3% (Jun 19, 2024) |
| Weeks tracked | 243 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fexofenadine HCl market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Camber Consumer Care manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fexofenadine HCl market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FEXOFENADINE HCL 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FEXOFENADINE HCL 60 MG TABLET, manufactured by Camber Consumer Care, is $0.1529 per EA (NDC 69230020105), effective Sep 30, 2026.
How has the price of FEXOFENADINE HCL 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for FEXOFENADINE HCL 60 MG TABLET has risen 7.9%. It has been tracked across 243 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for FEXOFENADINE HCL 60 MG TABLET?
Since Feb 9, 2022, the NADAC for FEXOFENADINE HCL 60 MG TABLET has ranged from a low of $0.1254 (May 22, 2024) to a high of $0.1994 (Apr 10, 2024), with a median of $0.1700 per EA.
Are there cheaper alternatives to FEXOFENADINE HCL 60 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FEXOFENADINE HCL 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FEXOFENADINE HCL 60 MG TABLET?
FEXOFENADINE HCL 60 MG TABLET (NDC 69230020105) is labeled by Camber Consumer Care, and CMS classifies it as a generic product.